Clinical application of 18 F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism
We evaluated the difference in parathyroid visualization on F-FCH PET/CT images obtained at 5 and 60 min, and quantitatively analyzed the mode of FCH uptake at different time points, to determine the best imaging time for FCH PET/CT. This retrospective study included 73 patients with hyperparathyroi...
Gespeichert in:
Veröffentlicht in: | Frontiers in endocrinology (Lausanne) 2023, Vol.14, p.1100056 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We evaluated the difference in parathyroid visualization on
F-FCH PET/CT images obtained at 5 and 60 min, and quantitatively analyzed the mode of FCH uptake at different time points, to determine the best imaging time for FCH PET/CT.
This retrospective study included 73 patients with hyperparathyroidism (HPT) who underwent
F-FCH PET/CT imaging between December 2017 and December 2021. The diagnostic efficiency of 5- and 60-min dual time point imaging for the diagnosis of hyperparathyroidism and parathyroid adenoma and hyperplasia, were compared using visual and quantitative analyses.
Dual-time
F-FCH PET/CT imaging visual analysis had diagnostic value for HPT. The receiver operating characteristic curve of PET/CT quantitative parameters for the diagnosis of HPT and lesions showed that the parathyroid/thyroid SUVmax ratio for 60-min imaging had a higher sensitivity and specificity (based on patient, sensitivity: 90.90% and specificity: 85.71%; based on focus, sensitivity: 83.06% and specificity: 85.71%) compared to that for 5-min imaging. PET/CT quantitative parameters can distinguish parathyroid adenoma and hyperplasia. The 60-min parathyroid SUVmax value had the highest diagnostic value (cutoff: 3.945; area under the curve: 0.783).
The quantitative parameters of 60min
F-FCH PET/CT have more advantages in aiding in the pathologica diagnosis and clinical treatment of HPT. |
---|---|
ISSN: | 1664-2392 1664-2392 |
DOI: | 10.3389/fendo.2023.1100056 |